CDT Equity Inc.
Organization details
- Legal name
- CDT Equity Inc.
- Former names
- Conduit Pharmaceuticals INC. Murphy Canyon Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Naples
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CDT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001896212
- EIN
- 87-3272543
Board of directors
-
Andrew Regan · Director · Chief Executive OfficerSince 2023
-
Chele Chiavacci Farley · DirectorSince 2023
-
David Tapolczay · Director · Chief Executive OfficerSince 2023
-
Faith L. Charles · DirectorSince 2023
-
Freda C. Lewis-Hall · DirectorSince 2023
-
James Bligh · Director · CFOSince 2023
-
Jennifer Isacoff McNealey · DirectorSince 2023
-
Simon Jeremy Fry · DirectorSince 2024
-
Ulrik K. Olsen · DirectorSince 2026
Chief executives
Director election results
Annual meeting of August 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.0%
Board connections
3 of this board's directors also sit on 5 other boards. 4 are in the same sector.
-
Abeona Therapeutics Inc. Same sectorvia Faith L. Charles
-
CNS Pharmaceuticals Inc. Same sectorvia Faith L. Charles
-
Cybin Inc. Same sectorvia Freda C. Lewis-Hall
- via Chele Chiavacci Farley
-
Pyxis Oncology Inc. Same sectorvia Freda C. Lewis-Hall
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,947,088
- 5 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 2026 | Andrew Regan 10% owner | Other | +499,616 | — | — |
| Oct 22, 2026 | Andrew Regan 10% owner | Other | +1,347,616 | — | — |
| Aug 28, 2026 | Andrew Regan Director, Officer (Chief Executive Officer) | Other | +5,436,830 | — | — |
| Aug 28, 2026 | Andrew Regan Director, Officer (Chief Executive Officer) | Open-market sale | −290 | — | — |
| Jun 18, 2026 | Prospect Capital Securities Ltd 10% owner | Open-market sale | −5,000 | $0.71 | $3,550 |
| Jun 18, 2026 | Prospect Capital Securities Ltd 10% owner | Open-market sale | −1,464,711 | $1.44 | $2,109,184 |
| Jun 18, 2026 | Prospect Capital Securities Ltd 10% owner | Open-market sale | −5,000 | $0.75 | $3,750 |
| Jun 18, 2026 | Prospect Capital Securities Ltd 10% owner | Open-market sale | −593,289 | $1.40 | $830,605 |
| May 13, 2026 | Andrew Regan Director, Officer (Chief Executive Officer) | Grant or award | +100,000 | $1.90 | $190,000 |
| Mar 24, 2026 | Andrew Regan Director, Officer (Chief Executive Officer) | Grant or award | +147,401 | — | — |
| Mar 17, 2026 | Prospect Capital Securities Ltd 10% owner | Other | +51,420,358 | — | — |
| Feb 19, 2026 | Prospect Capital Securities Ltd 10% owner | Other | −46,902 | — | — |
| Feb 19, 2026 | Chele Chiavacci Farley Director | Grant or award | +10,553 | $1.04 | $10,975 |
| Dec 8, 2025 | Andrew Regan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +224,800 | $1.79 | $402,392 |
| Sep 19, 2025 | Andrew Regan Director, Officer (Chief Executive Officer), 10% owner | Grant or award | +1,120,000 | $0.69 | $772,800 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about CDT Equity Inc.
Who is the CEO of CDT Equity Inc.?
David Tapolczay has been CDT Equity Inc.'s Chief Executive Officer since September 2023.
How many directors are on CDT Equity Inc.'s board?
CDT Equity Inc.'s board has 9 directors: Andrew Regan, Chele Chiavacci Farley, David Tapolczay, Faith L. Charles, Freda C. Lewis-Hall, James Bligh, Jennifer Isacoff McNealey, Simon Jeremy Fry and Ulrik K. Olsen.
Are CDT Equity Inc. insiders buying or selling shares?
Over the last 12 months, CDT Equity Inc. insiders made no open-market purchases and sold $2.9 million of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cdt-equity-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.